← Russell 3000 cross-section

SBC SBC Medical Group Holdings Inc

Trailing twelve months to 2026-06-30 · as filed 2026-08-13, not restated
Healthcare

Scale

Market cap
$417m
Revenue TTM
$175m
Net income TTM
$49m
Free cash flow
$62m
Composite score
93.0
Sector rank
#2487

Valuation

P / E
8.5
EV / EBITDA
3.9
EV / sales
1.5
FCF yield
14.80%
Earnings yield vs 10-yr
7.01pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
28.0%
EBITDA margin
39.2%
ROE
18.6%
ROIC
55.8%
Revenue growth

Insider activity, last 90 days

Net open-market
$0.00m
Buyers
0
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

The consumption tax on sales is calculated at 10% of gross sales. Prior to April 2025, revenue was based on a fixed amount to each MC and a fixed amount to each clinic of the MCs; starting from April 2025, the clinic-level monthly fee is determined based on the facility type, operational tenure, and operational performance of each clinic of the MCs, rather than a uniform flat fee for all clinics. Procurement Revenue The Company generates procurement services revenue by purchasing primarily advertising services and medical materials from qualified vendors on behalf of MCs to maintain brand quality consistency. …SBC Medical Group Holdings Inc, 10-Q, period ended 2026-06-30, filed 2026-08-13

Read the full passage →